Zosano Pharma Corp Litigation

Oct 8, 2021

Voluntary Dismissal

The plaintiff in this action has chosen not to proceed with the case. Once a case is voluntary dismissed, the courts will usually close the case and no further action will be taken.

Sep 1, 2021

Motion to Dismiss Granted

The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.

May 14, 2021

Motion to Dismiss

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

May 7, 2021

Scheduling Order

Mar 30, 2021

First Amended Complaint

A new complaint has been filed on behalf of certain investors in Zosano Pharma Corp. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

Feb 12, 2021

Scheduling Order

Feb 4, 2021

Appointment of Lead Plaintiff

The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.

Nov 6, 2020

Additional Complaint

Another plaintiff has filed a complaint on behalf of investors in Zosano Pharma Corp. The allegations and class definitions are substantively the same.

Oct 30, 2020

Scheduling Order

Oct 29, 2020

First Filed Complaint

A securities fraud class action complaint has been filed on behalf of certain investors in Zosano Pharma Corp.